Status:
UNKNOWN
Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Migraine
Thrombophilia
Eligibility:
All Genders
5-20 years
Phase:
NA
Brief Summary
Acute Migraine attacks can be related to vascular or coagulation activation. Previous studies found relative high incidence of prothrombotic events in Migraine. The present study intends to assess the...
Eligibility Criteria
Inclusion
- Patients at the pediatric age (5 to 20 ys old) suffering from Migraine attacks diagnosed by a neurologist.
Exclusion
- Patients with other underlying neurological conditions of coagulation diseases
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01905748
Start Date
August 1 2011
End Date
December 31 2020
Last Update
October 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ha'Emek Medical Center
Afula, Israel, 18101